The DOI matches its OpenAlex record; 40 of the 40 references it cites were found in a registry or an index.
Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance
Open accessAbstract
BACKGROUND: To directly compare traditional lipid ratios (total cholesterol [TC]/high density lipoprotein cholesterol [HDL-C], non-HDL-C/HDL-C, low density lipoprotein cholesterol [LDL-C]/HDL-C, and triglycerides [TG]/HDL-C), apolipoprotein B (apoB)/apolipoprotein A-I (apoA-I) ratio, visceral adiposity index (VAI), lipid accumulation product (LAP), and the product of TG and fasting glucose (TyG) for strength and independence as risk factors for insulin resistance (IR). METHODS: We conducted a cross-sectional analysis of 7629 Chinese adults using data from the China Health and Nutrition Survey 2009. RESULTS: For all lipid ratios (traditional lipid ratios and apoB/apoA-I), among both sexes, TG/HDL-C explained the most additional percentage of variation in HOMA-IR (2.9% in men, and 2.3% in women); for all variables of interest, the variability in HOMA-IR explained by VAI and TG/HDL-C were comparable; TyG had the most significant association with HOMA-IR, which explained 9.1% for men and 7.8% for women of the variability in HOMA-IR. Logistic regression analysis showed the similar patterns. Receiver operating characteristic (ROC) curve analysis showed that, among both sexes, TG/HDL-C was a better discriminator of IR than apoB/apoA-I; the area under the ROC curve (AUC) for VAI (0.695 in men and 0.682 in women) was greater than that for TG/HDL-C (AUC 0.665 in men and 0.664 in women); TyG presented the greatest value of AUC (0.709 in men and 0.711 in women). CONCLUSION: The apoB/apoA-I performs no better than any of the traditional lipid ratios in correlating with IR. The TG/HDL-C, VAI and TyG are better markers for early identification of IR individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0034 · Cited by 2,445
Guerrero-Romero, F., Simental-Mendía, L. E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M. G., Hernández-González, S. O., Jacques-Camarena, O., & Rodríguez-Morán, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0288 · Cited by 2,247
Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1825 · Cited by 1,751
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Hajer, G. R., van Haeften, T. W., & Visseren, F. L. J. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn387 · Cited by 1,410
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Walldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,229
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Kahn, H. S. (2005) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-5-26 · Cited by 968
Popkin, B. M., Du, S., Zhai, F., & Zhang, B. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp322 · Cited by 960
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61076-4 · Cited by 864
Lipids and Lipoproteins in Patients With Type 2 Diabetes
Krauss, R. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1496 · Cited by 756
McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 658
Is visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
Neeland, I. J., Turer, A. T., Ayers, C. R., Powell-Wiley, T. M., Vega, G. L., Farzaneh-Far, R., Grundy, S. M., Khera, A., McGuire, D. K., & de Lemos, J. A. (2012) · JAMA · doi:10.1001/2012.jama.11132 · Cited by 648
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome
Grundy, S. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00211-8 · Cited by 610
Walldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00666-9 · Cited by 534
Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes
Gastaldelli, A., Miyazaki, Y., Pettiti, M., Matsuda, M., Mahankali, S., Santini, E., DeFronzo, R. A., & Ferrannini, E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020696 · Cited by 289
Kim-Dorner, S.-J., Deuster, P. A., Zeno, S. A., Remaley, A. T., & Poth, M. (2010) · Metabolism · doi:10.1016/j.metabol.2009.07.027 · Cited by 184
Tan, C. Y., & Vidal-Puig, A. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360935 · Cited by 169
van der Steeg, W. A., Boekholdt, S. M., Stein, E. A., El-Harchaoui, K., Stroes, E. S. G., Sandhu, M. S., Wareham, N. J., Jukema, J. W., Luben, R., Zwinderman, A. H., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00007 · Cited by 165
Kannel, W. B., Vasan, R. S., Keyes, M. J., Sullivan, L. M., & Robins, S. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.09.109 · Cited by 164
Ohkura, T., Shiochi, H., Fujioka, Y., Sumi, K., Yamamoto, N., Matsuzawa, K., Izawa, S., Kinoshita, H., Ohkura, H., Kato, M., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-21 · Cited by 109
Taniguchi, A., Fukushima, M., Sakai, M., Miwa, K., Makita, T., Nagata, I., Nagasaka, S., Doi, K., Okumura, T., Fukuda, A., et al. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1766 · Cited by 108
Kimm, H., Lee, S. W., Lee, H. S., Shim, K. W., Cho, C. Y., Yun, J. E., & Jee, S. H. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0571 · Cited by 101
ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects
Sierra-Johnson, J., Romero‐Corral, A., Somers, V. K., López-Jiménez, F. A., Walldius, G., Hamsten, A., Hellénius, M.-L., & Fisher, R. M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm360 · Cited by 95
on behalf of the FIELD study investigators, Taskinen, M.-R., Barter, P. J., Ehnholm, C., Sullivan, D. R., Mann, K., Simes, J., Best, J. D., Hamwood, S., & Keech, A. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1806-9 · Cited by 94
Taniguchi, A., Nakai, Y., Sakai, M., Yoshii, S., Hamanaka, D., Hatae, Y., Kawata, M., Yamanouchi, K., Okumura, T., Doi, K., et al. (2002) · Metabolism · doi:10.1053/meta.2002.31984 · Cited by 74
Stein, E., Kushner, H., Gidding, S. S., & Falkner, B. E. (2007) · Metabolism · doi:10.1016/j.metabol.2007.02.008 · Cited by 40
Xiao, C., Watanabe, T., Zhang, Y., Trigatti, B. L., Szeto, L., Connelly, P. W., Marcovina, S. M., Vaisar, T., Heinecke, J. W., & Lewis, G. F. (2008) · Circulation Research · doi:10.1161/circresaha.108.178756 · Cited by 36
Hisamatsu, T., Fujiyoshi, A., Miura, K., Ohkubo, T., Kadota, A., Kadowaki, S., Kadowaki, T., Yamamoto, T., Miyagawa, N., Zaid, M., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.07.019 · Cited by 24
Is LDL-C Passed Its Prime? The Emerging Role of Non-HDL, LDL-P, and ApoB in CHD Risk Assessment
Davidson, M. H. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.172718 · Cited by 19
Leança, C. C., Nunes, V. S., Panzoldo, N. B., Zago, V. H. D. S., Parra, E. S., Cazita, P. M., Jauhiainen, M., Passarelli, M., Nakandakare, E. R., de Faria, E. C., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-173 · Cited by 18
Zhang, Z.-Q., Li-ping, H., Xie, X., Ling, W., Deng, J., Su, Y., & Chen, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104361 · Cited by 16
Cited by
Er, L.-K., Wu, S., Chou, H.-H., Hsu, L.-A., Teng, M.-S., Sun, Y.-C., & Ko, Y.-L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149731 · Cited by 708
The TyG index may predict the development of cardiovascular events
Sánchez‐Íñigo, L., Navarro‐González, D., Fernández‐Montero, A., Pastrana‐Delgado, J., & Martínez, J. A. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12583 · Cited by 663
Dang, K., Wang, X., Hu, J., Zhang, Y., Cheng, L., Qi, X., Liu, L., Ming, Z., Tao, X., & Li, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02115-9 · Cited by 599
Sánchez-García, A., Rodríguez-Gutiérrez, R., Mancillas-Adame, L., González-Nava, V., Díaz González-Colmenero, A., Solis, R. C., Álvarez-Villalobos, N. A., & González-González, J. G. (2020) · International Journal of Endocrinology · doi:10.1155/2020/4678526 · Cited by 510
Lim, J., Kim, J., Koo, S. H., & Kwon, G. C. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212963 · Cited by 464
Metadata
- Authors
- Du, T., Yuan, G., Zhang, M., Zhou, X., Sun, X., & Yu, X.
- Venue
- Cardiovascular Diabetology
- Publisher
- BioMed Central
- Published
- 2014-01-01
- Volume
- 13
- Issue
- 1
- Pages
- 146-146
- ISSN
- 1475-2840 (ISSN-L)
- OpenAlex
- W2109057881
- Cited by
- 620
- References
- 40
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.